InvestorsHub Logo
Followers 88
Posts 6655
Boards Moderated 1
Alias Born 09/18/2009

Re: All-Bidness post# 42718

Friday, 06/21/2024 2:11:40 PM

Friday, June 21, 2024 2:11:40 PM

Post# of 42808
What allowed Gracell to process CAR-T completion in 24 hours, instead of taking 6 weeks?

Why did the EMA want Novavax to prove their new covid vaccine could show the same results over time, and across a wider area?

In terms of the PREACH-M and RATinG studies, we know that CMML and aGvHD patients may finally have a cure.

Sorry to deduce that lenz may have improved the CAR-T and non-mRNA covid vaccine efficacies, based on speculation, without as much evidence as we see for CMML and aGvHD. I have noted the co-exclusive licensing deal announced between Sanofi and Novavax, for what that might be worth to you, ahead of evidence that lenz is the common denominator, and the licensed product.

There is probably nobody that is more eager for good news than I am, nor more disappointed when potential announcement dates come and go without news.

If people have no clue about what is happening, if they have no appreciation of what lenzilumab's success could mean to them as investors, and they would prefer to be left to wonder, then they should stop reading my posts. Or not. Because as time goes on, I see only MORE reason to be wildly optimistic, as I am. That should come as, "... no news."